Thyroid disorder Board decisions

The Veteran's limitations in performing activities of daily living are consistent with being unable to sustain himself in the community, warranting Tier 2 benefits under the PCAFC program.

The Board has dismissed the appeals for increased disability ratings for bilateral hearing loss, diabetes mellitus, type II with erectile dysfunction, coronary artery disease, and hypothyroidism as the Veteran withdrew his appeal prior to a decision being made.

The Board has granted the Veteran's claim for service connection for hypothyroidism and status post thyroidectomy and right thyroid nodules, finding that there is a current disability related to active service.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) due to service-connected disabilities, finding that his service-connected conditions do not render him unable to secure or follow a substantially gainful occupation.

The Veteran's claim for an initial compensable disability rating for Hashimoto's disease with hypothyroidism and complications is denied as the evidence does not support a higher rating.

The Board has determined that the Veteran's thyroid cancer is not related to service, and thus denied his claim for service connection.

The Veteran's appeals for higher ratings and effective dates have been dismissed as the Veteran withdrew his appeals.,The Board also remanded several issues related to service connection, including right knee osteoarthritis, IVDS, chronic right wrist sprain, OSA, COPD, and other conditions.

The Board has granted service connection for fibromyalgia and Hashimoto thyroid disease, both of which are related to the Veteran's exposure to contaminated water at Camp Lejeune.

The Board denied service connection for PTSD, sleep disturbances, anxiety, hypothyroidism, glaucoma, and hypertension. The Veteran's claims were not supported by the evidence of record.

The Board denied the Veteran's claim for service connection for hypothyroidism and thyroid cancer, finding that there is affirmative evidence to the contrary of a finding that the Veteran's conditions were incurred in service. The medical opinions provided by VA examiners supported this conclusion.

The Board has granted service connection for hypothyroidism and myasthenia gravis disease, finding that the Veteran's in-service exposure to hazardous materials is at least in balance with his current conditions. The Board also granted TDIU based on the Veteran's myasthenia gravis disease.

The Board has remanded both the service connection claims for thyroid cancer residuals and hypothyroidism due to potential exposure to herbicide agents in Vietnam, as well as contaminated water at Camp Lejeune. The Veteran will need a TERA-specific examination to assess his total exposure through all deployments.

The Veteran's heart disease, hypothyroidism, and hypertension are presumed to be associated with in-service exposure to herbicide agents. Therefore, the Board has granted service connection for these conditions.

The Board has remanded the claims of service connection for right ear hearing loss, hypothyroidism, chronic sinusitis, sleep apnea, and a psychiatric disability due to insufficient evidence or conflicting opinions.

The Veteran's appeal for a compensable rating for hypothyroidism was dismissed because she had already submitted a Higher-Level Review request for the same issue, and concurrent election of review under different lanes is prohibited.

The Veteran's claims for initial compensable rating for hypothyroidism, increased ratings for major depressive disorder with posttraumatic stress disorder, panic disorder and specific phobia, earlier effective dates for various conditions, and TDIU, SMC, and DEA are being remanded due to the need for additional medical opinions and evaluations.

The Board has remanded the claims for service connection for diabetes mellitus II and hypothyroidism as secondary to service-connected hepatitis C due to insufficient medical opinions.

The Veteran's service-connected disabilities, including hypothyroidism, PTSD, and diabetes mellitus, have prevented him from securing or following a substantially gainful occupation as of June 14, 2021. The Board has granted an effective date of June 14, 2021 for the TDIU award and DEA eligibility.

The Board denied eligibility for attorney fees based on past-due benefits awarded in the December 2024 Rating Decision, as the July 2024 claim was not on the same basis and did not involve the same benefits.

The Veteran's claim for an initial compensable rating for hypothyroidism is denied as there are no compensable residuals or impacted systems attributed to her thyroid condition.